Stay updated on Eribulin + Pembrolizumab in Soft Tissue Sarcomas Clinical Trial

Sign up to get notified when there's something new on the Eribulin + Pembrolizumab in Soft Tissue Sarcomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Eribulin + Pembrolizumab in Soft Tissue Sarcomas Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-06T19:54:51.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The page now renders a 403 Forbidden error instead of the study record, indicating access is denied to this entry. The page shows a minimal header, a 403 message, and a Home button.
    Difference
    20%
    Check dated 2026-09-22T23:15:47.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    A new revision tag v3.7.0 is now shown, replacing the previous v3.6.6, indicating an updated version of the page content.
    Difference
    0.1%
    Check dated 2026-09-15T21:56:44.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Revision label updated to v3.6.6, indicating a small backend/content-management update.
    Difference
    0.1%
    Check dated 2026-09-01T21:50:11.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The page revision label changed from v3.6.4 to v3.6.5, indicating a small maintenance update to the page.
    Difference
    0.0%
    Check dated 2026-08-11T22:43:17.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.3 to v3.6.4, indicating a minor update to the page's content or layout.
    Difference
    0.0%
    Check dated 2026-07-28T15:35:01.000Z thumbnail image

Stay in the know with updates to Eribulin + Pembrolizumab in Soft Tissue Sarcomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Eribulin + Pembrolizumab in Soft Tissue Sarcomas Clinical Trial page.